Khoo, Saye H., FitzGerald, Richard and Saunders, Geoffrey , (2022) A randomised -controlled Phase 2 trial of molnupiravir in unvaccinated and vaccinated individuals with early SARS-CoV-2. The Lancet Infectious Diseases. (doi:10.1016/S1473-3099(22)00644-2.).
Record type:
Article
Text
2022 A randomicsed controlled phase 2 trial of molnupiravir in unvaccinated and vaccinated
- Version of Record
Available under License Creative Commons Attribution.
Download (552kB)
More information
e-pub ahead of print date: 19 October 2022
Identifiers
Local EPrints ID: 482960
URI: http://eprints.soton.ac.uk/id/eprint/482960
ISSN: 1473-3099
PURE UUID: 7a6b1d48-1cd0-4282-a2d8-d3a4f6787452
Catalogue record
Date deposited: 17 Oct 2023 16:56
Last modified: 18 Mar 2024 03:30
Export record
Altmetrics
Contributors
Author:
Saye H. Khoo
Author:
Richard FitzGerald
Author:
Geoffrey Saunders
Corporate Author: AGILE CST-2 Study Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.